NRP1 and neoplasm: To determine whether NRP1 targeting can elicit strong antitumor effects in a broad range of GBMs, we performed in vivo growth competition assays in which control (GFP-labeled) or NRP1 shRNA (RFP-labeled) tumor cells were mixed in a 1:1 ratio and coinjected into mouse brains.